Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating carboplatin chemotherapy before surgery in men with high-risk prostate cancer who carry BRCA1 or BRCA2 mutations; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING